$1.16
-0.14-10.77%
At close: -
$1.16
0.000.00%
After Hours: 6:44 PM EDT
Comments
Loading...
Brainstorm Cell Stock Short Interest Report | NASDAQ:BCLI | Benzinga
Short interest in Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) increased during the last reporting period, rising from 137.22K to 346.65K. This put 6.41% of the company's publicly available shares short.
Short interest in Brainstorm Cell Corp (XNAS:BCLI) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.
Based on the recent average volume of 610.66K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
346.65K
Short Interest %
6.41%
Days to Cover
1
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics I | 04/15/2025 | 04/25/2025 | 6.41% | 5,405,805 | 346,646 | 610,656 | 1 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 03/31/2025 | 04/09/2025 | 2.54% | 5,405,805 | 137,216 | 46,715 | 2.94 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 03/14/2025 | 03/25/2025 | 2.27% | 5,405,805 | 122,765 | 16,867 | 7.28 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 02/28/2025 | 03/11/2025 | 1.98% | 5,405,805 | 107,230 | 37,546 | 2.86 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 02/14/2025 | 02/26/2025 | 2.05% | 5,405,805 | 110,846 | 32,897 | 3.37 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 01/31/2025 | 02/11/2025 | 1.69% | 5,405,805 | 91,385 | 63,905 | 1.43 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 01/15/2025 | 01/27/2025 | 3.20% | 5,405,805 | 172,989 | 57,202 | 3.02 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 12/31/2024 | 01/10/2025 | 1.73% | 5,405,805 | 93,267 | 159,130 | 1 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 12/13/2024 | 12/24/2024 | 2.82% | 5,405,805 | 152,370 | 85,033 | 1.79 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 11/29/2024 | 12/10/2024 | 2.74% | 5,405,805 | 148,229 | 99,445 | 1.49 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 11/15/2024 | 11/26/2024 | 3.22% | 5,405,805 | 173,850 | 162,693 | 1.07 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 10/31/2024 | 11/11/2024 | 2.19% | 5,017,985 | 109,802 | 87,664 | 1.25 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 10/15/2024 | 10/24/2024 | 3.31% | 5,017,985 | 165,892 | 87,883 | 1.89 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 09/30/2024 | 10/09/2024 | 37.24% | 5,017,985 | 1,868,815 | 387,661 | 4.82 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 09/13/2024 | 09/24/2024 | 1.86% | 75,269,777 | 1,399,016 | 229,978 | 6.08 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 08/30/2024 | 09/11/2024 | 1.71% | 75,269,777 | 1,286,721 | 290,915 | 4.42 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 08/15/2024 | 08/26/2024 | 2.15% | 75,269,777 | 1,617,894 | 673,587 | 2.4 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 07/31/2024 | 08/09/2024 | 1.39% | 76,836,964 | 1,065,531 | 362,829 | 2.94 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 07/15/2024 | 07/24/2024 | 1.41% | 76,836,964 | 1,080,538 | 533,231 | 2.03 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 06/28/2024 | 07/10/2024 | 2.13% | 68,918,200 | 1,468,709 | 716,077 | 2.05 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 06/14/2024 | 06/26/2024 | 1.32% | 67,335,703 | 890,588 | 793,969 | 1.12 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 05/31/2024 | 06/11/2024 | 1.67% | 67,335,703 | 1,121,353 | 497,781 | 2.25 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 05/15/2024 | 05/24/2024 | 2.10% | 67,335,703 | 1,414,121 | 805,129 | 1.76 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 04/30/2024 | 05/09/2024 | 3.20% | 65,597,037 | 2,098,310 | 570,888 | 3.68 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 04/15/2024 | 04/24/2024 | 3.04% | 65,597,037 | 1,991,679 | 1,382,034 | 1.44 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 03/28/2024 | 04/09/2024 | 2.05% | 65,597,037 | 1,343,163 | 1,894,389 | 1 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 03/15/2024 | 03/26/2024 | 1.82% | 46,641,147 | 850,265 | 518,858 | 1.64 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 02/29/2024 | 03/11/2024 | 2.29% | 46,641,147 | 1,067,002 | 804,804 | 1.33 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 02/15/2024 | 02/27/2024 | 2.65% | 46,641,147 | 1,234,664 | 795,127 | 1.55 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 01/31/2024 | 02/09/2024 | 4.36% | 46,641,147 | 2,034,743 | 796,006 | 2.56 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 01/12/2024 | 01/24/2024 | 5.12% | 46,641,147 | 2,386,380 | 1,077,964 | 2.21 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 12/29/2023 | 01/10/2024 | 9.02% | 46,641,147 | 4,209,007 | 4,318,485 | 1 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 12/15/2023 | 12/27/2023 | 7.20% | 46,641,147 | 3,357,336 | 4,893,971 | 1 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 11/30/2023 | 12/11/2023 | 7.51% | 46,641,147 | 3,500,593 | 3,994,582 | 1 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 11/15/2023 | 11/27/2023 | 8.09% | 46,641,147 | 3,772,910 | 1,035,083 | 3.65 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 10/31/2023 | 11/09/2023 | 8.43% | 42,357,533 | 3,570,310 | 1,349,681 | 2.65 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 10/13/2023 | 10/24/2023 | 10.60% | 42,357,533 | 4,488,098 | 6,806,546 | 1 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 09/29/2023 | 10/10/2023 | 10.48% | 42,357,533 | 4,438,584 | 2,181,900 | 2.03 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 09/15/2023 | 09/26/2023 | 8.30% | 42,357,533 | 3,516,408 | 459,430 | 7.65 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 08/31/2023 | 09/12/2023 | 7.60% | 42,357,533 | 3,217,393 | 258,674 | 12.44 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 08/15/2023 | 08/24/2023 | 6.27% | 42,357,533 | 2,657,188 | 158,665 | 16.75 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 07/31/2023 | 08/09/2023 | 6.51% | 40,804,342 | 2,656,607 | 245,900 | 10.8 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 07/14/2023 | 07/25/2023 | 6.90% | 40,804,342 | 2,814,466 | 224,328 | 12.55 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 06/30/2023 | 07/12/2023 | 7.62% | 36,750,287 | 2,799,423 | 273,448 | 10.24 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 06/15/2023 | 06/27/2023 | 7.41% | 36,750,287 | 2,722,048 | 215,135 | 12.65 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 05/31/2023 | 06/09/2023 | 7.83% | 36,750,287 | 2,878,209 | 233,815 | 12.31 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 05/15/2023 | 05/24/2023 | 7.81% | 36,750,287 | 2,869,444 | 205,224 | 13.98 | Get Alert |
| BCLI | Brainstorm Cell Therapeutics I | 04/28/2023 | 05/09/2023 | 8.84% | 35,816,984 | 3,164,880 | 278,114 | 11.38 | Get Alert |
Looking for the most shorted stocks?
